The accreditors of this session require that you periodically check in to verify that you are still attentive. Please click the button below to indicate that you are.
GERD-INDUCED ALTERATIONS IN HYDROGEN SULFIDE SIGNALING AS THE FUNDAMENTAL MECHANISM OF BARRETT’S ESOPHAGUS PATHOGENESIS

Figure 1. Gene set enrichment analyses of Barrett’s esophagus biopsies taken 1 week after stopping PPIs showing significant upregulation of gene pathways for HIF-1α, angiogenesis, and EMT. NES=normalized enrichment score.

Figure 2. Barrett’s spheroids treated with acidic bile salt solutions (A&B) show increased protrusions into the collagen I matrix while exhibiting increased nuclear staining for HIF-1α and re-localization of CDH1 from the membrane to the cytoplasm. DAPI was used as a nuclear counterstain. Matrigel served as a control condition. Scale bar=50 µm; for Collagen I images scale bar=125 µm.
Methods: Barrett’s epithelial cell lines (BAR-T and BAR-10T) were treated with a 15-minute exposure to A&B medium (pH 5.5) for 1 or 3 days. We assessed VEGF mRNA levels by qPCR, and cell migration by transwell assays. We used siRNA to knockdown endogenous APE1, which we confirmed by assessing APE1 mRNA; scrambled siRNA served as control. We then used constructs resistant to APE1 siRNA to overexpress: 1) wild-type APE1, 2) a redox-dead APE1 mutant that lacks redox function, or 3) empty vector; these constructs contained a hemagglutinin (HA) tag that we used to confirm protein overexpression by Western blot. We treated the cells either with the novel APE1 redox inhibitor APX2009 or its analog RN7-58, which does not inhibit APE1 redox activity (both at 7µM concentration).
Results: A&B significantly increased migration rates in empty vector-containing control BAR-T cells; this increased migration could be blocked by APE1 knockdown with siRNA (Figure 1). A&B also significantly increased migration rates in BAR-T cells that overexpressed wild-type APE1, but not in cells that overexpressed the APE1 redox-dead mutant (Figure 1). Exposure to A&B significantly increased VEGF mRNA expression and migration rates (Figure 2) in both BAR-T and BAR-10T cells treated with RN7-58, but not in those cells treated with APX2009.
Conclusion: In Barrett’s epithelial cells, A&B increase VEGF mRNA expression and cell migration through the redox function of APE1. These findings suggest that APE1 mediates the GERD-induced increases in VEGF production that trigger EMT in BE. Thus, targeting the redox function of APE1 with agents such as APX2009 might prevent the development of SSIM in Barrett’s patients.

Figure 1. APE1 redox function mediates migration of BAR-T cells induced by exposure to acidic bile salt solutions (A&B). Upper panels show density of BAR-T cells in transwell assays (an index of migration). Lower panel graph depicts cell migration rates relative to untreated, empty vector control cells. Cells were counted in 10 separate high-power fields. Scale bar = 275 µm ***p<0.0001 compared with non-A&B treated BAR-T cells containing an empty vector and control siRNA; +++ p<0.001 compared with A&B treated BAR-T cells containing an empty vector and control siRNA

Figure 2. APX2009, a novel APE1 redox inhibitor, prevents migration of BAR-T and BAR-10T cells exposed to acid bile salt solutions (A&B). RN7-58 is an APX2009 analog that does not inhibit APE1 redox activity Cells were counted in 10 separate high-power fields. Scale bar = 275 µm ***p<0.001 compared with non-A&B treated corresponding control; +++ p<0.001 compared with RN5-78 and A&B treated cells
Methods: This study utilized public databases and local RNA-sequencing database for differential gene expression analysis, gene set enrichment assay (GSEA), correlation analysis and patients’ survival analysis. Exposure to acidic bile salts (ABS), was employed to mimic reflux conditions in vitro. EAC cell line models, 3D organotypic culture, tumorosphere, L2-IL1b transgenic mouse model and human EAC tissue samples were used to identify mechanisms of NOTCH activation under reflux conditions.
Results: The bioinformatic analysis and in vitro cell lines studies demonstrated significant upregulation of several NOTCH signaling components in EAC. Activation of NOTCH signaling was confirmed by nuclear accumulation of active NOTCH1 intracellular domain (NICD) after cleavage, along with upregulation of NOTCH targets in EAC cells in response to ABS. Additional investigations identified DLL1 as the predominant ligand contributing to NOTCH1 activation. We discovered a novel cross-talk between APE1 redox function, reflux-induced inflammation, and DLL1 up-regulation where NF-κB can directly bind to and transcriptionally regulate the expression of DLL1. Moreover, our studies revealed that APE1-redox-activated NF-κB/DLL1/NICD signaling axis is crucial to promote cancer cell stem-like properties in response to reflux conditions. Co-overexpression of APE1 and DLL1 was also detected in the gastroesophageal junctions of genetically engineered L2-IL1b mouse model and human EAC tissue microarrays. High levels of DLL1 were associated with poor overall survival in patients with EAC.
Conclusion: These findings uncover a unique mechanism that links redox balance, inflammation, and embryonic development (NOTCH) together into a common pro-tumorigenic pathway that is intrinsic to EAC cells.

Schematic summary of APE1-redox-mediated NF-κB-DLL1-NOTCH activation in response to acidic bile salts (ABS) in oesophageal adenocarcinoma. Exposure to ABS, the in vitro mimic of GERD, increases APE1 protein level and activates APE1-redox-dependent transcription factor, NF-κB, which consequently upregulates DLL1 transcription by directly binding to DLL1 promoter region in the signal sending cells. Accumulated DLL1 protein on cell surface facilitates NOTCH1 cleavage in the signal receiving cells, releasing the active form of NOTCH1 receptor, NOTCH intracellular domain (NICD), which is translocated into cell nucleus, forms transcriptional complex with RBPJ and MAML, and activates transcription of downstream targets like HES1 and HEY1. APE1 redox-specific inhibitor, E3330, effectively blocks this ABS-activated NF-κB/DLL1/NICD signaling axis.
We investigated for the first time if chronic GERD affects the endogenous H2S biosynthesis, possibly predisposing to BE development. We evaluated the impact of H2S bioavailability on gastric H+ secretion as a target for proton pump inhibitors (PPIs) counteracting clinical GERD and BE development.
We implemented an animal GERD model based on microsurgical esophago-gastroduodenal anastomosis (EGDA). Gastric acid secretion was examined in rats surgically equipped with gastric fistulas. In parallel, we employed optimized in vitro models based on human-derived healthy (EPC2), GERD-exposed (NES-G2T) and Barrett’s metaplasia (BAR-T) esophageal cell lines +/- CRISPR-Cas9-induced knockout of H2S-producing enzymes. Moreover, we analyzed H2S-enzymes at protein level in human endoscopic biopsies of BE-metaplasia and squamous epithelial segments.
We observed increased protein expression of CTH in BE vs physiological mucosa in clinical samples. Similarly, we noted that CTH and CBS protein contents were elevated in esophageal mucosa of EGDA-rats. Increased CBS and CTH expression was accompanied by decreased capacity of esophageal mucosa to produce H2S. Similarly, in vitro model of GERD reflected by chronic treatment with acidified bile mixture (BM), revealed a fall in H2S content (by LC-MS/MS) in squamous EPC2 and NES-G2T cells. We also observed that selective knockout of CBS or CTH in EPC2 cells led to decreased H2S content and enhanced susceptibility to BM expressed by decreased cell viability (MTT assay). Metaplastic BAR-T cells maintained its H2S level, being more resistant to BM. Additionally, we observed that i.g. administration of H2S-releasing NaHS decreased, while pharmacological inhibition of H2S biosynthesis by PAG elevated gastric acid output in rats with gastric fistulas.
We conclude that mixed reflux induced the fall in H2S bioavailability in squamous epithelium activating metaplasia-specific molecular pattern. The metaplastic cells in adaptative manner expressed higher capacity to produce H2S increasing their resistance to chronic GERD. We also propose that H2S prodrugs possess the ability to inhibit gastric H+ secretion suggesting that H2S-based therapeutics could be considered as an alternative or additional treatment method of GERD.
[Funding: National Science Centre (Poland) (UMO-2016/23/D/NZ4/01913 and UMO-2019/33/B/NZ4/00616)]
Speakers
